India’s First Gene Therapy Centre of Excellence to Launch in Hyderabad
India’s First Gene Therapy Centre of Excellence to Launch in Hyderabad
Miltenyi Biotec announces India’s first Cell and Gene Therapy Centre of Excellence in Hyderabad’s Genome Valley. The Miltenyi Innovation and Technology Centre (MITC) will drive biomedical research, immunology, and cancer therapy advancements, fostering collaboration among scientists, physicians, and industry experts.
India’s First Gene Therapy Centre of Excellence to Launch in Hyderabad
Hyderabad is set to become a hub for cutting-edge biomedical research with the launch of India’s first dedicated Cell and Gene Therapy Centre of Excellence. Miltenyi Biotec, a global leader in cell and gene therapy solutions, has announced the establishment of the Miltenyi Innovation and Technology Centre (MITC) in Genome Valley.
This state-of-the-art facility will serve as a collaborative hub for researchers, physicians, and industry experts, aiming to revolutionize the treatment of cancer and other life-threatening diseases.
The MITC marks a significant step in India’s growing life sciences ecosystem, bridging the gap between scientific research, clinical applications, and biotechnology advancements.
✔ Location: Genome Valley, Hyderabad
✔ Size: 1,800 square meters
✔ Focus Areas: Gene therapy, cell therapy, immunology, and cancer research
With Hyderabad emerging as a global biotech hub, this centre will strengthen India’s position in advanced medical research and accelerate breakthroughs in personalized medicine.
Centre to Foster Innovation & Collaboration
1. A Research & Development Hub
The MITC will support biomedical advancements by integrating:
✔ Advanced cell processing technologies
✔ Next-generation gene therapy tools
✔ High-throughput immunology research techniques
2. Collaboration with Industry & Academia
The centre will bridge industry and academia, facilitating partnerships between:
✔ Pharmaceutical companies developing cutting-edge gene therapies
✔ Academic researchers working on novel treatment approaches
✔ Clinicians and physicians treating patients with rare diseases
3. Skill Development & Knowledge Sharing
The MITC will conduct:
✔ Workshops & seminars on cell and gene therapy innovations
✔ Hands-on training for researchers & biotech professionals
✔ Symposiums on immunology, stem cell research, and oncology
By equipping scientists and healthcare professionals with the latest gene therapy technologies, the centre will accelerate drug development and precision medicine.
Expert Insights on MITC’s Impact
Dr. Kathrin Misera-Lang (Consul General, Federal Republic of Germany)
📌 “This state-of-the-art facility will significantly enhance cell and gene therapies, improving healthcare outcomes and reinforcing India’s leadership in life sciences.”
Dr. Toon Overstijns (Managing Director, Miltenyi Biomedicine)
📌 “MITC is a pivotal step in accelerating the global revolution in cell and gene therapies.”
Dr. Boris Stoffel (Chief Commercial Officer, Miltenyi Biotec)
📌 “This centre will drive advancements in biomedical research, supporting the scientific and medical community in developing new therapies for diseases with limited treatment options.”
Why MITC Matters for India’s Healthcare Sector
The Miltenyi Innovation and Technology Centre is a game-changer in the field of biotechnology and regenerative medicine.
✔ Bridging Research & Clinical Applications – Enables direct translation of lab research into real-world treatments.
✔ Driving Innovation in Cancer & Rare Diseases – Focuses on developing breakthrough therapies for conditions with limited treatment options.
✔ Strengthening India’s Position in Life Sciences – Reinforces Hyderabad’s role as a global biotech and pharmaceutical hub.
✔ Training the Next Generation of Scientists – Offers workshops and hands-on training for upcoming biotech professionals.
The Future of Gene Therapy in India
With advancements in gene-editing technologies like CRISPR and CAR-T cell therapy, India’s biotech sector is at a turning point. The MITC will contribute to:
✔ Personalized Medicine Development – Tailoring treatments for individual patients based on genetic profiles.
✔ Biopharmaceutical Innovations – Accelerating drug discovery for cancer, genetic disorders, and autoimmune diseases.
✔ Global Collaborations – Positioning India as a key player in international biomedical research.
This initiative opens new doors for medical breakthroughs, transforming patient care, disease treatment, and biotech innovations.
The Miltenyi Innovation and Technology Centre (MITC) in Hyderabad’s Genome Valley marks a new era in gene therapy research and biotechnology. By fostering collaboration between scientists, physicians, and industry leaders, this centre will drive biomedical advancements, enhance India’s global reputation in life sciences, and pave the way for next-generation medical treatments.
Also read: India Poised to Stay World’s Fastest Growing Economy in 2025-26: RBI Bulletin
Frequently Asked Questions (FAQs)
1. What is the purpose of the MITC in Hyderabad?
MITC is India’s first dedicated Cell and Gene Therapy Centre of Excellence, aiming to advance research in cancer, immunology, and genetic medicine.
2. Where is the MITC located?
The centre is located in Genome Valley, Hyderabad, a leading biotech hub in India.
3. How will MITC contribute to India’s healthcare sector?
It will drive research in gene therapy, provide training to scientists, and support pharmaceutical innovations, improving healthcare outcomes.
4. Who will benefit from the MITC?
✔ Researchers & Scientists – Access to advanced gene therapy tools.
✔ Physicians & Clinicians – Collaboration on cutting-edge treatments.
✔ Patients – Development of personalized and innovative therapies.
5. What diseases will MITC focus on?
✔ Cancer
✔ Genetic Disorders
✔ Autoimmune Diseases
✔ Rare and Inherited Conditions
With the MITC’s launch, Hyderabad is set to become a global leader in cell and gene therapy research, transforming the future of medicine in India. 🚀
Last Updated on: Tuesday, February 25, 2025 2:33 pm by Admin | Published by: The Statesman India Team on Tuesday, February 25, 2025 2:33 pm | News Categories: India
About Us: The Statesman India covers the latest News on Current News, Business, Sports, Tech, Entertainment, Lifestyle, Automobiles, and more, led by Editor-in-Chief Ankur Srivastava. Stay connected on Facebook, Instagram, LinkedIn, X (formerly Twitter), Google News, and Whatsapp Channel.
Disclaimer: At The Statesman India, we are committed to providing accurate, reliable, and thoroughly verified information, sourced from trusted media outlets. For more details, please visit our About, Disclaimer, Terms & Conditions, and Privacy Policy. If you have any questions, feedback, or concerns, feel free to contact us through email.
Contact Us: newssites1234@gmail.com
About The Author
